Author:
Messer Shawn A.,Kirby Jeffrey T.,Sader Helio S.,Fritsche Thomas R.,Jones Ronald N.
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)
Reference22 articles.
1. Hajjeh, R. A., Sofair, A. N., Harrison, L. E. et al. (2004). Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. Journal of Clinical Microbiology42, 1519–27.
2. Edmond, M. B., Wallace, S. E., McClish, D. K. et al. (1999). Nosocomial bloodstream infections in US hospitals: a three year analysis. Clinical Infectious Diseases29, 239–44.
3. Arevalo, M. P., Carrillo-Munoz, A. J., Salgado, J. et al. (2003). Antifungal activity of the echinocandin anidulafungin (VER002, LY-303366) against yeast pathogens: a comparative study with M27-A microdilution method. Journal of Antimicrobial Chemotherapy51, 163–6.
4. Marco, F., Danes, C., Almela, M. et al. (2003). Trends in frequency and in vitro susceptibilities to antifungal agents, including voriconazole and anidulafungin, of Candida bloodstream isolates. Results from a six-year study (1996-2001). Diagnostic Microbiology and Infectious Disease46, 259–64.
5. National Committee for Clinical Laboratory Standards. (2002). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts—Second Edition: Approved Standard M27-A2. NCCLS, Wayne, PA, USA.
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献